Rcra waste number U089 en es it fr

Rcra waste number U089 Brand names, Rcra waste number U089 Analogs

Rcra waste number U089 Brand Names Mixture

  • No information avaliable

Rcra waste number U089 Chemical_Formula

C22H46O

Rcra waste number U089 RX_link

No information avaliable

Rcra waste number U089 fda sheet

Rcra_waste_number_U089 FDA

Rcra waste number U089 msds (material safety sheet)

Rcra_waste_number_U089 MSDS

Rcra waste number U089 Synthesis Reference

No information avaliable

Rcra waste number U089 Molecular Weight

326.6 g/mol

Rcra waste number U089 Melting Point

65 - 72 oC

Rcra waste number U089 H2O Solubility

No information avaliable

Rcra waste number U089 State

Solid

Rcra waste number U089 LogP

9.017

Rcra waste number U089 Dosage Forms

Topical cream (10%)

Rcra waste number U089 Indication

For the topical treatment of recurrent oral-facial herpes simplex episodes (cold sores or fever blisters).

Rcra waste number U089 Pharmacology

Docosanol is a saturated 22-carbon aliphatic alcohol which exhibits antiviral activity against many lipid enveloped viruses including herpes simplex virus (HSV). Docosanol speeds the healing of cold sores and fever blisters on the face or lips. It also relieves the accompanying symptoms, including tingling, pain, burning, and itching. Docosanol cannot, however, prevent cold sores or fever blisters from appearing.

Rcra waste number U089 Absorption

Topical absorption has been shown to be minimal under conditions reflecting normal clinical use.

Rcra waste number U089 side effects and Toxicity

Symptoms of overdose include headache, abdominal pain, increased serum lipase, nausea, dyspepsia, dizziness, and hyperbilirubinemia.

Rcra waste number U089 Patient Information

No information avaliable

Rcra waste number U089 Organisms Affected

Herpes simplex virus